+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Monkeypox Antibody Test Reagent Market - Global Forecast 2025-2030- Product Image
Monkeypox Antibody Test Reagent Market - Global Forecast 2025-2030- Product Image
Sale

Monkeypox Antibody Test Reagent Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6125124
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The monkeypox antibody reagent market is rapidly adapting to shifting public health priorities, with innovation in serological testing tools and evolving trade policies influencing industry growth. As global health systems emphasize preparedness, organizations are seeking specialized and scalable antibody testing solutions that align with emerging regulatory landscapes and operational demands.

Market Snapshot: Monkeypox Antibody Reagent Market

The monkeypox antibody reagent market is witnessing robust growth, driven by surging demand for highly accurate serological assays capable of detecting IgA, IgG, IgM, and total antibodies. Advancements in immunoassay technologies—including next-generation automated platforms and rapid lateral flow formats—are enabling organizations to conduct reliable diagnostics and epidemiological surveillance at greater speed and scale. Key players are strategically expanding their global footprints, supported by both public and private health sector investments as regional dynamics shape adoption patterns across the Americas, EMEA, and Asia-Pacific.

Scope & Segmentation

  • Test Types: IgA, IgG, IgM, Total Antibody
  • Technology Platforms: Chemiluminescence immunoassays (CLIA), Enzyme-linked immunosorbent assays (ELISA), Rapid lateral flow devices with colloidal gold or fluorescent readouts
  • End Users: Diagnostic laboratories, Hospitals, Public health laboratories, Research institutes
  • Sample Types: Plasma, Serum, Whole blood
  • Product Formats: Bulk reagents, Kits
  • Applications: Clinical diagnosis in central labs and point-of-care settings, Epidemiological surveillance (including contact tracing, seroprevalence surveys), Research, Vaccine development
  • Sales Channels: Direct government and private contracts, National and regional distributors, Online sales
  • Regions Covered: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Thermo Fisher Scientific Inc., Roche Diagnostics International AG, Abbott Laboratories, QIAGEN N.V., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., bioMérieux SA, DiaSorin S.p.A., Bio-Techne Corporation, Virion\Serion GmbH

Key Takeaways

  • Rising concern over emerging pathogens drives laboratories to invest in robust monkeypox antibody testing infrastructure able to support outbreak monitoring, vaccine evaluation, and routine diagnostics.
  • Technological innovation enables streamlined workflows, faster turnaround, and higher reproducibility, with automation and digital health integration extending reach beyond centralized labs.
  • Diagnostic platforms offer diverse capabilities, with some designed for centralized high-throughput testing and others tailored for decentralized or field-based applications.
  • Strategic manufacturing expansions and collaborative agreements with regional distributors are helping suppliers secure continuity of supply and maintain service levels in response to surging market demand.
  • Shift toward customized reagent services is meeting the specific requirements of research institutions, clinical diagnostics, and vaccine development programs.
  • Regional partnerships and regulatory harmonization accelerate product deployment, especially in regions prioritizing public health resilience and surveillance.

Tariff Impact on Monkeypox Antibody Reagent Market

Evolving US tariff policies on imported biochemical components and reagents are prompting suppliers to assess sourcing and manufacturing strategies. Increased import levies drive both global and domestic companies to pursue vertical integration and alternative distribution models, with international partners enhancing regional warehousing and logistics capabilities to maintain stable supply. These measures, along with local production incentives, are facilitating more resilient supply chains and shaping competitive dynamics in the market.

Methodology & Data Sources

This report is based on rigorous secondary research across peer-reviewed articles, regulatory filings, and public health records, supplemented by targeted interviews with laboratory directors, executive leadership, and public sector officials. Data triangulation was used to validate findings, with cross-functional expert review and systematic quality checks throughout research design and synthesis.

Why This Report Matters

  • Provides a comprehensive view of how monkeypox antibody reagent innovations and regulatory shifts are influencing buyer and supplier strategies across industries.
  • Helps leadership teams evaluate segment and regional opportunities, optimize procurement, and allocate resources for strategic growth or risk mitigation.
  • Supports executive decision-making with actionable intelligence on evolving sales channels, partnership models, and technology adoption.

Conclusion

Emerging diagnostics, strategic sourcing, and regulatory agility are redefining the monkeypox antibody reagent market. Stakeholders leveraging these insights are positioned to bolster operational resilience and advance public health security in a shifting landscape.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing demand for high-throughput monkeypox antibody test reagents in centralized clinical laboratories
5.2. Expansion of authorized monkeypox serology kits under emergency use authorization in major markets
5.3. Implementation of next-generation immunoassay platforms for quantitative monkeypox antibody profiling in research settings
5.4. Rising partnerships between biotech firms and public health agencies to scale up monkeypox antibody test distribution networks
5.5. Development of lateral flow immunochromatographic assays for rapid point-of-care monkeypox antibody detection in outbreak zones
5.6. Integration of digital data reporting solutions into monkeypox antibody testing workflows to enhance epidemiological surveillance capabilities
5.7. Growing focus on cross-reactivity studies to improve specificity of monkeypox antibody reagents against other orthopoxviruses
5.8. Adoption of recombinant antigen technologies to boost sensitivity and batch consistency of monkeypox serological reagents
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Monkeypox Antibody Test Reagent Market, by Test Type
8.1. Introduction
8.2. Iga
8.3. Igg
8.4. Igm
8.5. Total Antibody
9. Monkeypox Antibody Test Reagent Market, by Technology Platform
9.1. Introduction
9.2. Clia
9.3. Elisa
9.4. Rapid Lateral Flow
9.4.1. Colloidal Gold
9.4.2. Fluorescent
10. Monkeypox Antibody Test Reagent Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratory
10.3. Hospital
10.4. Public Health Laboratory
10.5. Research Institute
11. Monkeypox Antibody Test Reagent Market, by Sample Type
11.1. Introduction
11.2. Plasma
11.3. Serum
11.4. Whole Blood
12. Monkeypox Antibody Test Reagent Market, by Product Format
12.1. Introduction
12.2. Bulk Reagent
12.3. Kit
13. Monkeypox Antibody Test Reagent Market, by Application
13.1. Introduction
13.2. Clinical Diagnosis
13.2.1. Central Lab
13.2.2. Point of Care
13.3. Epidemiological Surveillance
13.3.1. Contact Tracing Studies
13.3.2. Seroprevalence Surveys
13.4. Research
13.5. Vaccine Development
14. Monkeypox Antibody Test Reagent Market, by Sales Channel
14.1. Introduction
14.2. Direct Sales
14.2.1. Government Contracts
14.2.2. Private Contracts
14.3. Distributor
14.3.1. National Distributors
14.3.2. Regional Distributors
14.4. Online Sales
15. Americas Monkeypox Antibody Test Reagent Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Monkeypox Antibody Test Reagent Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Monkeypox Antibody Test Reagent Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Thermo Fisher Scientific Inc.
18.3.2. Roche Diagnostics International AG
18.3.3. Abbott Laboratories
18.3.4. QIAGEN N.V.
18.3.5. PerkinElmer, Inc.
18.3.6. Bio-Rad Laboratories, Inc.
18.3.7. BioMérieux SA
18.3.8. DiaSorin S.p.A.
18.3.9. Bio-Techne Corporation
18.3.10. Virion\Serion GmbH
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. MONKEYPOX ANTIBODY TEST REAGENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. MONKEYPOX ANTIBODY TEST REAGENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. MONKEYPOX ANTIBODY TEST REAGENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. MONKEYPOX ANTIBODY TEST REAGENT MARKET: RESEARCHAI
FIGURE 30. MONKEYPOX ANTIBODY TEST REAGENT MARKET: RESEARCHSTATISTICS
FIGURE 31. MONKEYPOX ANTIBODY TEST REAGENT MARKET: RESEARCHCONTACTS
FIGURE 32. MONKEYPOX ANTIBODY TEST REAGENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MONKEYPOX ANTIBODY TEST REAGENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGG, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGG, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGM, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGM, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TOTAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TOTAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COLLOIDAL GOLD, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COLLOIDAL GOLD, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY FLUORESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY FLUORESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PUBLIC HEALTH LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PUBLIC HEALTH LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY BULK REAGENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY BULK REAGENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY KIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY KIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CENTRAL LAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CENTRAL LAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CONTACT TRACING STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CONTACT TRACING STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SEROPREVALENCE SURVEYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SEROPREVALENCE SURVEYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY GOVERNMENT CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY GOVERNMENT CONTRACTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRIVATE CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRIVATE CONTRACTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 154. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 155. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 156. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 157. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 160. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 161. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 162. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 163. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 166. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 167. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 168. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 169. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 172. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 173. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 174. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 175. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 178. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 179. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 180. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 181. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 186. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 187. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 196. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 197. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 198. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Monkeypox Antibody Test Reagent market report include:
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics International AG
  • Abbott Laboratories
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • DiaSorin S.p.A.
  • Bio-Techne Corporation
  • Virion\Serion GmbH

Related Topics

Related Reports

Monkeypox Antigen Test Reagent Market - Global Forecast 2025-2030 - Product Image

Monkeypox Antigen Test Reagent Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Monkeypox Rapid Test Kit Market - Global Forecast 2025-2030 - Product Image

Monkeypox Rapid Test Kit Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Lateral Flow Assays Market Report and Forecast 2025-2034 - Product Image

Lateral Flow Assays Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Lateral Flow Assays - Global Strategic Business Report - Product Image

Lateral Flow Assays - Global Strategic Business Report

  • Report
  • 461 Pages
  • Global
From
Lateral Flow Assays Market Report 2025 - Product Image

Lateral Flow Assays Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.